| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Chief Oper. &Tech. Officer | SVP, Product Development &CTO +1 more
1 company
Simpson Curran serves as a Chief Executive Officer at RGNX. Across recent SEC filings that breaks down to 0 buys and 30 sells. Those positions are worth an estimated $4.4M at current prices.
Historically, Simpson Curran's trades have earned a middling insider score of 64/100 across 5 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +29.7%.
The biggest single holding is RGNX (~$4.4M) as Chief Executive Officer. The recent filings there lean toward selling, a net 389,841 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 9, 2025 | RGNX Regenxbio Inc. | Chief Executive Officer | Sell10b5-1 | 20,811 | $12.62 | $262,634.82 | -8.8% | +25.2% | -33.7% | |
| Sep 29, 2025 | RGNX Regenxbio Inc. | Chief Executive Officer | Sell10b5-1 | 7,624 | $10.03 | $76,468.72 | -3.1% | +45.2% | -24.4% | |
| Sep 10, 2025 | RGNX Regenxbio Inc. | Chief Executive Officer | Sell10b5-1 | 7,734 | $10.02 | $77,494.68 | -3.1% | +32.9% | -10.6% | |
| Aug 1, 2024 | RGNX Regenxbio Inc. | Chief Executive Officer | Sell10b5-1 | 100 | $15.00 | $1,500.00 | - | -33.6% | -38.5% | |
| Jul 29, 2024 | RGNX Regenxbio Inc. | Chief Executive Officer | Sell10b5-1 | 9,648 | $15.04 | $145,105.92 | -5.4% | -34.6% | -41.4% | |
| Jan 14, 2021 | RGNX Regenxbio Inc. | Chief Oper. &Tech. Officer | Sale+OE | 13,312 | $50.01 | $665,767.12 | -42.9% | - | - | |
| Jan 7, 2021 | RGNX Regenxbio Inc. | Chief Oper. &Tech. Officer | Sale+OE | 5,185 | $50.01 | $259,301.85 | -22.6% | - | - | |
| Feb 11, 2020 | RGNX Regenxbio Inc. | SVP, Product Development &CTO | Sale+OE | 56,993 | $50.28 | $2,865,635.78 | -93.5% | - | - | |
| Feb 5, 2020 | RGNX Regenxbio Inc. | SVP, Product Development &CTO | Sale+OE | 5,637 | $50.00 | $281,850.00 | -19.9% | - | - | |
| Jan 17, 2020 | RGNX Regenxbio Inc. | SVP, Product Development &CTO | Sale+OE | 5,922 | $50.00 | $296,100.00 | -20.4% | - | - |